Omuro, Antonio M P <br/><br/>
High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.  [electronic resource] 

 -  Cancer  Jun 2005 
 - 2344-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.21033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Brain Neoplasms--secondary<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cohort Studies<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Humans<br/>Incidence<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Meningeal Neoplasms--secondary<br/>Middle Aged<br/>Neoplasm Staging<br/>Quinazolines--therapeutic use<br/>Survival Rate<br/>Treatment Failure